申请人:Mayweg Alexander
公开号:US20050250769A1
公开(公告)日:2005-11-10
The present invention relates to compounds of formula I
and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors.
本发明涉及公式I的化合物及其药用盐。这些化合物可用于治疗和/或预防与CB1受体调节相关的疾病。